Michael Chancley Jr.’s personal experience with PrEP informs his work at PrEP4All as he advocates for expanded access and ...
Daily Maverick on MSN
Anti-HIV jab due in six weeks but funding cuts hollow out delivery system
The uptake of the once-every-six-month HIV prevention jab lenacapavir (LEN) in South Africa will be heavily affected by the ...
Gilead Sciences gears up for Q1 earnings with HIV drugs driving growth, but cell therapy headwinds and rising costs could ...
Experts fear losing ground to virus even as the end of the HIV epidemic is in sight, and say decline in infant testing is ‘particularly concerning’ ...
It could be possible to end HIV transmissions in Ireland — but to get there, we need action," said Pádraig Rice, the Social ...
The FCT has launched LenPrEP, a free long-acting HIV prevention injection. This twice-a-year medication is now available to ...
The US still delivered HIV treatment, in the form of antiretroviral drugs, to about 20 million people from July through ...
In this era of the HIV epidemic, talking saves lives. It pierces stigma and turns ordinary conversation into something ...
Unlike daily PrEP, the injection is administered once every six months, offering continuous protection over that period.
England should prioritise socially excluded populations England’s latest HIV action plan, launched in December, commits to ...
(Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) submission for bictegravir 75 mg/lenacapavir 50 mg (BIC/LEN) – an investigational, ...
The FCT is introducing Lenacapavir, a new long-acting injectable HIV prevention drug. This PrEP option is administered every ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results